Macroeconomic and Fiscal Effects of Increased Efficiency in Medicine Procurement: A General Equilibrium Analysis of the Colombian Health System

Peer Reviewed icon Peer Reviewed
Author
Ávila-Montealegre, Oscar ;
Botero García, Jesús ;
Lozano Espitia, Luis ;
Melo-Becerra, Ligia ;
Ortiz Hoyos, José Luis ;
Rodríguez-Ávila, Jesús
Date issued
December 2024
Subject
Delivery of Health Care;
Medicines Pricing;
Health;
Procurement;
Saving;
Health Expenditure;
Taxation;
Macroeconomy;
Fiscal Policy;
Regulation;
Tax System;
Health Services;
Gross Domestic Product;
Pharmaceutical Policy
JEL code
C68 - Computable General Equilibrium Models;
D58 - Computable and Other Applied General Equilibrium Models;
E62 - Fiscal Policy;
H21 - Efficiency • Optimal Taxation;
H51 - Government Expenditures and Health;
I11 - Analysis of Health Care Markets;
I18 - Government Policy • Regulation • Public Health
Country
Colombia;
Colombia
Category
Monographs
This study analyzes the macroeconomic and fiscal effects of greater efficiency in medicines procurement in Colombia, using both static (computable) and dynamic general equilibrium models. The findings indicate that implementing an efficient drug procurement policy could reduce the total health system spending, with potential savings of up to 8.4% in the short term and up to 10.8% in the long term. These savings could be reinvested within the health system, allocated to other sectors, or used to reduce tax burden on capital, consumption, or social contributions. The latter option would increase production by up to 1.1%, investment by 1.7% and consumption by 0.8%. Potential measures to achieve such efficiency gains include promoting and purchasing generic drugs, conducting joint procurement, and implementing price regulation.
Generative AI enabled